BigClassActions.com
Advertisement
Class Action News

Class Action News

Class Action Legal News articles include legal news and lawsuit information about lawsuits filed, settlements reached and verdicts rendered in class action cases dealing with personal injury, defective products, bad drugs and other consumer law related news issues. Many of these articles include interviews from top legal professionals with guidance on legal recourse options from losses resulting from bad drugs, medical malpractice, investment fraud, personal injury, defective products and negligent employers.

  • Why the Courts Should Know What Pharmaceutical Reps Tell Doctors
    Why the Courts Should Know What Pharmaceutical Reps Tell Doctors
    April 28, 2014

    Houston, TX The story of the drug Vioxx speaks volumes about the way drug companies market their products to consumers and to the doctors that ultimately prescribe those drugs.

  • Merck & Co. to Pay $4.85 Billion in Personal Injury Cases Due to Vioxx
    Merck & Co. to Pay $4.85 Billion in Personal Injury Cases Due to Vioxx
    March 22, 2008

    Trenton, N.J. Vioxx is the impetus feeding the fire of over 44,000 personal injury lawsuits being exacted against Pharmaceutical manufacturer Merck & Co. The drug has caused several incidences of heart ailments, strokes, and even cases of death from its side effects. The former painkiller was eliminated from the market in 2004. The 44,000 personal injury cases are just from plaintiffs in the United States. Former patients that used Vioxx in 18 other nations have stepped forward demanding a refund for the money spent on the drug. Also, health care professionals and stockholders in these nations are demanding repayment for the losses they've incurred from the drug going South. Fresh lawsuits from overseas areas continue to come in.

  • Vioxx Settlement: Merck Offers $4.85 Billion
    Vioxx Settlement: Merck Offers $4.85 Billion
    November 9, 2007

    Whitehouse Station, NJ In a stunning announcement that also provides a peek into the vaults of a pharmaceutical giant, it was revealed late yesterday that Merck & Co. Inc has thrown the first volley that it hopes will result in a settlement of Vioxx lawsuits to the tune of $4.85 billion.

  • FDA Colludes With Merck To Avoid Vioxx Liability - Part II
    FDA Colludes With Merck To Avoid Vioxx Liability - Part II
    June 13, 2007

    Washington, DC: Legal experts say the recent court ruling in Bush's home state of Texas that failure-to-warn claims against Merck by Vioxx victims in state courts are preempted is particularly egregious due to the FDA's failure to protect the public against Merck's deceptive mass-marketing of Vioxx as a safe drug for basically 5 years.

  • FDA Colludes With Merck To Avoid Vioxx Liability - Part I
    FDA Colludes With Merck To Avoid Vioxx Liability - Part I
    June 12, 2007

    Washington, DC: The FDA is still helping Merck escape liability for the Vioxx disaster. Texas Judge Randy Wilson, who is overseeing the Texas state court proceedings, recently granted Merck's motion to dismiss possibly thousands of lawsuits, essentially because the FDA refuses to acknowledge that Merck concealed information about the safety risks of Vioxx.

  • Vioxx Stroke Risk could last for Years
    Vioxx Stroke Risk could last for Years
    May 16, 2007

    New York, NY Former users of Vioxx could be at risk for developing strokes for years after they have discontinued using the medication, a prominent public health expert has reported.

  • Merck Legal Team makes a Killing off losing Vioxx Strategy
    Merck Legal Team makes a Killing off losing Vioxx Strategy
    July 5, 2006

    Not much has changed at Merck since Vioxx was pulled off the market. The only difference for shareholders is that instead of spending hundreds of millions of dollars a year to promote Vioxx, the attorney's fees are now costing hundreds of millions of dollars a year.

  • Vioxx: Anger and Agony
    Vioxx: Anger and Agony
    June 22, 2006

    "My doctor called in September 2004 and told me to stop taking Vioxx because he heard about cardiovascular problems associated with it. One month later, I got the letter from Merck, but the damage had already been done," says Linda Long of Balton, Georgia.

  • Merck Litigation Strategy - Destroy Expert Witnesses
    Merck Litigation Strategy - Destroy Expert Witnesses
    May 22, 2006

    Former Vioxx users could be at risk of developing strokes for years, a prominent scientist said this week after evaluating new data from a 107-page report on patients who were followed for a year after they stopped the drug

  • Merck Caught Misrepresenting Vioxx Risks Again
    Merck Caught Misrepresenting Vioxx Risks Again
    May 17, 2006

    Although Merck has long maintained that the risks associated with Vioxx occur after long-term use, a recent study in the Canadian Medical Association Journal, says the drug may raise the risk of heart attack for patients taking Vioxx for less than 2 weeks.

Request Legal Help